Von Willebrand Disease in the Netherlands
(De ziekte van von Willebrand in Nederland)
2011-10-26
Doctoral Thesis
| Related Files |
|---|
View PDF Version
(111026_Wee, Eva .Marie.pdf, 0.9MB) |
|
View PDF Version
(stellingen Wee.pdf, 0.0MB) |
Based on previous epidemiologic studies it is estimated that in the Netherlands the referral based prevalence of moderate to severe von Willebrand disease (VWD) is approximately 1 in 10,000 (1650 patients). This does not include patients with mild type 1 disease (VWF levels 30-50 U/dL), or individuals with borderline VWF levels with a mild bleeding phenotype, of which the prevalence is higher and may even reach 1:100 individuals. Despite the frequency of the disease only a limited number of studies have been performed on clinical presentation, determinants of bleeding phenotype and Quality of Life (QoL). Therefore we have initiated a nationwide study on moderate and severe VWD in the Netherlands, the Willebrand in the Netherlands study, the WiN study.
Stichting Haemophilia
CSL Behring
- patient
- von willebrand disease
- willebrand
- study
- disease
- score
- level
- fviii
- type 3 vwd
- treatment
- vwd patients
- women
- factor
- children
- hr-qol
- j thromb haemost
- health
- netherland
- blood
- phenotype
